Laboratorios Farmaceuticos Rovi company profile
Company profile
Laboratorios Farmaceuticos Rovi has 1,950 employees and is headquartered in Pozuelo de Alarcón, Spain.
Rovi's prescription medicines, including Ameride, Exxiv, Neparvis and Mysimba, form the core of its activity, and the group also sells hospital products such as contrast agents and catheter care under the Fibrilin name. Its portfolio spans cardiology, women's health, anaesthesia and pain, the central nervous system, urology, endocrinology and respiratory care. Beyond its own brands, the company runs contract manufacturing for injectable forms, covering sterile filling, labelling, serialisation and packaging, and it also makes low-molecular-weight heparin. Its markets include Spain, the European Union, other OECD countries and other regions.
In the fiscal year ended December 2025, revenue reached 743.5 million euros, down 2.7% from the previous year, and net profit was 140.4 million euros. The company employed 1,950 people and is headquartered in Pozuelo de Alarcón, Spain. Incorporated in 1946, it operates as a subsidiary of Norbel Inversiones, S.L.
Company facts
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- Spain
- Headquarters
- Calle José Isbert, 2, 28223, Pozuelo de Alarcón
- Employees
- 1,950
- Chief executive
- Juan Lopez-Belmonte Encina
- Founded
- 1946
- Fiscal year
- January - December
- Listing
- ROVI · BME
- Indices
- IBEX 35
- Currency
- EUR
- ISIN
- ES0157261019
- Website
- rovi.es
Laboratorios Farmaceuticos Rovi and its competitors
The most similar companies by business and size
| Company | Country | Market cap | Employees | Operating margin | P/E (trailing 12 months) |
|---|---|---|---|---|---|
| Laboratorios Farmaceuticos RoviROVI | Spain | $3.93B | 1,950 | 20.2% | 17.4 |
| Siegfried HoldingSFZN | Switzerland | $3.53B | 4,454 | 16.7% | 17.3 |
| AlmirallALM | Spain | $2.53B | 2,108 | 9.6% | 32.1 |
| FagronFAGR | Belgium | $1.9B | 4,880 | 14.3% | 18.8 |
| H. LundbeckHLUN.A | Denmark | $8.49B | 5,000 | 24.4% | 14.2 |
| Faes FarmaFAE | Spain | $1.73B | 2,677 | 13.0% | 18.7 |
Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.
Compare Laboratorios Farmaceuticos Rovi with its competitors
